爱朋医疗：未来将适时开展股权激励等措施

Core Viewpoint - Aipeng Medical (300753) is actively exploring new equity incentive mechanisms in response to the growing focus on brain-computer interface technology and its own strategic initiatives in this area [1] Group 1: Company Initiatives - Aipeng Medical has previously implemented a three-year restricted stock incentive plan, which concluded in 2021 [1] - The company is currently accelerating its efforts in the brain-computer interface innovation business [1] Group 2: Future Plans - Aipeng Medical is developing a systematic strategic talent cultivation and incentive system [1] - The company plans to research and potentially implement new equity incentive measures based on its operational conditions in the future [1]